Dynamics of T-cell Responses Following COVID-19 mRNA Vaccination and Breakthrough Infection in Older Adults.

COVID-19 activation-induced marker assay cellular immune response mRNA vaccines older adults

Journal

Pathogens & immunity
ISSN: 2469-2964
Titre abrégé: Pathog Immun
Pays: United States
ID NLM: 101683909

Informations de publication

Date de publication:
2023
Historique:
received: 25 07 2023
accepted: 18 09 2023
medline: 30 11 2023
pubmed: 30 11 2023
entrez: 30 11 2023
Statut: epublish

Résumé

While older adults generally mount weaker antibody responses to a primary COVID-19 vaccine series, T-cell responses remain less well characterized in this population. We compared SARS-CoV-2 spike-specific T-cell responses after 2- and 3-dose COVID-19 mRNA vaccination and subsequent breakthrough infection in older and younger adults. We quantified CD4+ and CD8+ T-cells reactive to overlapping peptides spanning the ancestral SARS-CoV-2 spike protein in 40 older adults (median age 79) and 50 younger health care workers (median age 39), all COVID-19 naive, using an activation-induced marker assay. T-cell responses were further assessed in 24 participants, including 8 older adults, who subsequently experienced their first SARS-CoV-2 breakthrough infection. A third COVID-19 mRNA vaccine dose significantly boosted spike-specific CD4+ and CD8+ T-cell frequencies to above 2-dose levels in older and younger adults. T-cell frequencies did not significantly differ between older and younger adults after either dose. Multivariable analyses adjusting for sociodemographic, health, and vaccine-related variables confirmed that older age was not associated with impaired cellular responses. Instead, the strongest predictors of CD4+ and CD8+ T-cell frequencies post-third-dose were their corresponding post-second-dose frequencies. Breakthrough infection significantly increased both CD4+ and CD8+ T-cell frequencies, to comparable levels in older and younger adults. Exploratory analyses revealed an association between HLA-A*02:03 and higher post-vaccination CD8+ T-cell frequencies, which may be attributable to numerous strong-binding HLA-A*02:03-specific CD8+ T-cell epitopes in the spike protein. Older adults mount robust T-cell responses to 2- and 3-dose COVID-19 mRNA vaccination, which are further boosted following breakthrough infection.

Identifiants

pubmed: 38035132
doi: 10.20411/pai.v8i1.613
pii: pai.v8i1.613
pmc: PMC10686373
doi:

Types de publication

Journal Article

Langues

eng

Pagination

117-135

Informations de copyright

Copyright © 2023 Pathogens and Immunity.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest to declare.

Références

Nature. 2020 Oct;586(7830):594-599
pubmed: 32998157
J Infect Dis. 2022 Apr 1;225(7):1129-1140
pubmed: 34888688
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Nat Aging. 2023 Jan;3(1):82-92
pubmed: 37118516
Nature. 2020 Aug;584(7821):430-436
pubmed: 32640463
J Clin Microbiol. 2012 Jun;50(6):1936-42
pubmed: 22403431
JAMA. 2020 May 12;323(18):1775-1776
pubmed: 32203977
N Engl J Med. 2007 Oct 4;357(14):1373-81
pubmed: 17914038
Nat Aging. 2022 Oct;2(10):896-905
pubmed: 37118289
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
J Infect Dis. 2007 Jun 1;195(11):1694-704
pubmed: 17471440
Nature. 2021 Aug;596(7872):417-422
pubmed: 34192737
J Infect Dis. 2022 Sep 21;226(6):983-994
pubmed: 35543278
Nat Rev Immunol. 2019 Sep;19(9):573-583
pubmed: 31186548
Lancet. 2005 Oct 1;366(9492):1165-74
pubmed: 16198765
Clin Infect Dis. 2021 Dec 6;73(11):2065-2072
pubmed: 33906236
Nat Immunol. 2022 Feb;23(2):186-193
pubmed: 35105982
N Engl J Med. 2021 Dec 9;385(24):e84
pubmed: 34614326
Nat Immunol. 2013 May;14(5):428-36
pubmed: 23598398
Nucleic Acids Res. 2020 Jul 2;48(W1):W449-W454
pubmed: 32406916
Nat Med. 2022 May;28(5):1050-1062
pubmed: 35177862
Immunity. 2021 Sep 14;54(9):2133-2142.e3
pubmed: 34453880
Hum Immunol. 2022 Dec;83(12):797-802
pubmed: 36229378
Clin Infect Dis. 2022 Nov 30;75(11):1980-1992
pubmed: 35438175
EClinicalMedicine. 2023 Apr;58:101926
pubmed: 37034357
Virus Res. 2021 Nov;305:198579
pubmed: 34560183
Immunogenetics. 2023 Jun;75(3):309-320
pubmed: 36534127
JAMA Netw Open. 2022 Jun 1;5(6):e2218505
pubmed: 35749115
HLA. 2023 Sep;102(3):301-315
pubmed: 37010080
Viruses. 2021 Apr 28;13(5):
pubmed: 33925055
Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9440-5
pubmed: 12883005
N Engl J Med. 2022 Jan 27;386(4):340-350
pubmed: 35021002
Front Immunol. 2013 Jun 04;4:131
pubmed: 23761790
Open Forum Infect Dis. 2023 Feb 09;10(3):ofad073
pubmed: 36910697

Auteurs

Sneha Datwani (S)

Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada.

Rebecca Kalikawe (R)

Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada.

Francis Mwimanzi (F)

Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada.

Sarah Speckmaier (S)

British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada.

Richard Liang (R)

British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada.

Yurou Sang (Y)

Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada.

Rachel Waterworth (R)

Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada.

Fatima Yaseen (F)

Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, Canada.

Hope R Lapointe (HR)

British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada.

Evan Barad (E)

Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada.
British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada.

Mari L DeMarco (ML)

Division of Medical Microbiology and Virology, St. Paul's Hospital, Vancouver, Canada.
Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.

Daniel T Holmes (DT)

Division of Medical Microbiology and Virology, St. Paul's Hospital, Vancouver, Canada.
Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.

Janet Simons (J)

Division of Medical Microbiology and Virology, St. Paul's Hospital, Vancouver, Canada.
Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.

Julio S G Montaner (JSG)

Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, Canada.
Department of Medicine, University of British Columbia, Vancouver, Canada.

Marc G Romney (MG)

Division of Medical Microbiology and Virology, St. Paul's Hospital, Vancouver, Canada.
Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.

Zabrina L Brumme (ZL)

Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada.
British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada.

Mark A Brockman (MA)

Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada.
British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada.
Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, Canada.

Classifications MeSH